Tuesday 10 December 2013

Ebiox Completes a Distribution Agreement for Livinguard

With a number of key areas now identified as vehicles for cross infection, the objective of Ebiox as a provider of Infection Prevention and Control Products is to offer a product portfolio which will give the tools to combat infection in these identified areas.

It is well publicised that hands, the environment and surgical instruments are factors in Healthcare Acquired Infections for which Ebiox has a focussed range of products targeting these areas.

Studies show that Healthcare Workers clothing, patient attire and soft fabrics such as curtains are also vehicles for cross infection. So to try and break this chain Ebiox is now working with a company Livinguard who manufactures a patented range of medical clothing and items.

With the use of multiple coating applications Ebiox can over a range of clothing which is;

           Anti-microbial for up to 75 washes
           Hydrophobic which prevents penetration of fluids
           Hydrophilic for wearers comfort. This is enhanced by the use of
           high quality non linting Poly/Cotton fabric
           Stain resistent for easy laundering

Livinguard kills micro-organisms by a "mechnical" action rather than chemical. The textile is coated with billions of nano sized polymeric knives, spaced in a way that when bacteria for example hits the textile they are physically pierced, killing them.

Due to this being a mechanical action and not chemical there is no risk of resistance.

The textiles have gone through many tests, and has recently passed the EN13795, the European Standard for Surgical Drapes and Gowns for use in the Operating Theatre.

Ebiox believes this is an excellent addition to their portfolio, meeting their objective of providing products which will help close down many of the avenues of cross infection.

Ebiox Signs an Exclusive Distribution Agreement for the Kingdom of Saudi Arabia

It is with great pleasure to announce that Ebiox has signed and exclusive agreement for the distribution of their Infection Prevention and Control product portfolio for the Kingdom of Saudi Arabia.
We are are very confident that our distributor partner there, ScienPharma will gain success in what is potentially an excellent opportunity for both companies.